0001179110-18-013566.txt : 20181207 0001179110-18-013566.hdr.sgml : 20181207 20181207171509 ACCESSION NUMBER: 0001179110-18-013566 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181204 FILED AS OF DATE: 20181207 DATE AS OF CHANGE: 20181207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schumacher Laura J CENTRAL INDEX KEY: 0001319245 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35565 FILM NUMBER: 181224217 MAIL ADDRESS: STREET 1: 1 N. WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AbbVie Inc. CENTRAL INDEX KEY: 0001551152 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320375147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 BUSINESS PHONE: (847) 932-7900 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 4 1 edgar.xml FORM 4 - X0306 4 2018-12-04 0 0001551152 AbbVie Inc. ABBV 0001319245 Schumacher Laura J 1 N. WAUKEGAN ROAD NORTH CHICAGO IL 60064 0 1 0 0 Executive Vice President Common stock, $0.01 par value 2018-12-04 4 M 0 94140 51.42 A 192398 D Common stock, $0.01 par value 2018-12-04 4 S 0 33198 94.3418 D 159200 D Common stock, $0.01 par value 2018-12-04 4 S 0 41642 93.6647 D 117558 D Common stock, $0.01 par value 2018-12-04 4 S 0 10000 92.3705 D 107558 D Common stock, $0.01 par value 2018-12-04 4 S 0 9300 91.7745 D 98258 D Option (Right to buy) 51.42 2018-12-04 4 M 0 94140 0 D 2015-02-20 2024-02-19 Common Stock 94140 0 D The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.98 to $94.98, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.00 to $93.97, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.98 to $92.97, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.515 to $92.97, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The transactions reported on this Form 4 were made pursuant to a previously adopted plan complying with Rule 10b5-1(c). Steven L. Scrogham, attorney-in-fact for Laura J. Schumacher 2018-12-07